Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Bristol_Myers_Squibb
|
| gptkbp:acquisitionYear |
2017
|
| gptkbp:focusesOn |
gptkb:immunotherapy
immunology inflammatory diseases |
| gptkbp:foundedIn |
2015
|
| gptkbp:founder |
gptkb:Gary_D._Glick
|
| gptkbp:headquartersLocation |
gptkb:Boston,_Massachusetts,_United_States
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:subsidiary |
gptkb:Bristol_Myers_Squibb
gptkb:IFM_Due gptkb:IFM_Quattro gptkb:IFM_Tre |
| gptkbp:website |
https://www.ifmthera.com/
|
| gptkbp:bfsParent |
gptkb:Bristol_Myers_Squibb
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
IFM Therapeutics
|